drugset / Trial / NCT00268151
Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung Cancer
Phase 1
Terminated
24 enrolled
University of Louisville
James Graham Brown Cancer Center · collabSanofi · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the most suitable dose of Oxaliplatin that can be safely given in combination with a low fixed dose of Capecitabine and a limited volume of radiation in patients with non-small cell lung cancer.
Timeline
- Start
- 2005-02
- Primary completion
- 2007-02
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxaliplatin | Small molecule | — | — |
| Background | Capecitabine | Small molecule | — | — |